{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zmax&page=4", "query": { "intervention": "Zmax", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 228, "total_pages": 23, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zmax&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zmax&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T02:51:22.722Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05796362", "title": "A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infectious Disease", "Drug Effect", "Clinical Infection" ], "interventions": [ { "name": "Azithromycin Oleogel (Oral and Rectal)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 18, "start_date": "2024-08-08", "completion_date": "2025-11-25", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05796362" }, { "nct_id": "NCT00431964", "title": "Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "azithromycin 250 mg tablets", "type": "DRUG" }, { "name": "placebo tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CF Therapeutics Development Network Coordinating Center", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 263, "start_date": "2007-02", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-08-19", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Hartford, Connecticut • Atlanta, Georgia + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00431964" }, { "nct_id": "NCT00643149", "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tonsillitis" ], "interventions": [ { "name": "amoxicillin", "type": "DRUG" }, { "name": "azithromycin SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 693, "start_date": "2003-05", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2011-05-17", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 33, "location_summary": "Hoover, Alabama • Pelham, Alabama • Fresno, California + 20 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Pelham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643149" }, { "nct_id": "NCT00105469", "title": "Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Conjunctivitis" ], "interventions": [ { "name": "AzaSite", "type": "DRUG" }, { "name": "Tobramycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 743, "start_date": "2004-07", "completion_date": "2005-10", "has_results": true, "last_update_posted_date": "2013-12-16", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Littleton, Colorado • Atlantis, Florida + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Atlantis", "state": "Florida" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Jupiter", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00105469" }, { "nct_id": "NCT04358068", "title": "Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19", "SARS-CoV 2" ], "interventions": [ { "name": "Hydroxychloroquine (HCQ)", "type": "DRUG" }, { "name": "Azithromycin (Azithro)", "type": "DRUG" }, { "name": "Placebo for Hydroxychloroquine", "type": "DRUG" }, { "name": "Placebo for Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2020-05-13", "completion_date": "2020-07-08", "has_results": true, "last_update_posted_date": "2021-11-16", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 11, "location_summary": "Birmingham, Alabama • San Diego, California • Torrance, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04358068" }, { "nct_id": "NCT01949363", "title": "The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gonorrhoea" ], "interventions": [ { "name": "Cefixime", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 25, "start_date": "2013-12", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2019-01-17", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01949363" }, { "nct_id": "NCT04335552", "title": "Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "SARS-CoV-2" ], "interventions": [ { "name": "Standard of care", "type": "OTHER" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 11, "start_date": "2020-04-17", "completion_date": "2020-06-26", "has_results": true, "last_update_posted_date": "2021-05-17", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 4, "location_summary": "Durham, North Carolina • Raleigh, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04335552" }, { "nct_id": "NCT00035347", "title": "Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Community-Acquired Pneumonia (CAP)" ], "interventions": [ { "name": "IV azithromycin", "type": "DRUG" }, { "name": "ceftriaxone", "type": "DRUG" }, { "name": "oral azithromycin", "type": "DRUG" }, { "name": "IV levofloxacin", "type": "DRUG" }, { "name": "oral levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 219, "start_date": "2001-01", "completion_date": "2002-06", "has_results": false, "last_update_posted_date": "2017-03-10", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Long Beach, California • Sylmar, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00035347" }, { "nct_id": "NCT02960503", "title": "Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 0, "start_date": "2016-09", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2018-10-02", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02960503" }, { "nct_id": "NCT00834756", "title": "Azithromycin 600 Mg Tablets, Fasting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Azithromycin 600 mg Tablet", "type": "DRUG" }, { "name": "Zithromax® 600 mg Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2002-09", "completion_date": "2002-10", "has_results": true, "last_update_posted_date": "2024-08-19", "last_synced_at": "2026-11-13T02:51:22.722Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00834756" } ] }